Immunogenicity and Safety of Inactivated Enterovirus 71 Vaccine in Children Aged 36–71 Months

A Double-Blind, Randomized, Controlled, Non-inferiority Phase III Trial

Zhang, Lifen
Gao, Fan
Zeng, Gang
Yang, Haitao
Zhu, Taotao
Yang, Shuangmin
Meng, Xing
Mao, Qunying
Liu, Xiaoqiang

Yunnan Center for Disease Control and Prevention, Kunming, China
National Institutes for Food and Drug Control, Beijing, China
Sinovac Biotech Co., Ltd, Beijing, China

Corresponding Author: Xiaoqiang Liu, PhD, Yunnan Center for Disease Control and Prevention, No. 158, Dongsi Street, Xishan District, Kunming 650034, Yunnan, China. E-mail: [email protected].

The first three authors contributed equally to the manuscript. The last two authors contributed equally to the manuscript.

Received June 26, 2020

Accepted October 27, 2020

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

Journal of the Pediatric Infectious Diseases Society 10(4):p 440-447, April 2021. | DOI: 10.1093/jpids/piaa129